[BiO BB] Adopting Integrated R&D Informatics Systems
Jim Prudhomme
jprudhomme at healthtech.com
Wed Dec 3 16:41:24 EST 2008
Final Conference Details Posted for:
CHIs Adopting Integrated R&D Informatics Systems
February 25-27, 2009
Moscone North Convention Center, San Francisco, CA
http://www.tri-conference.com/09_ird.asp
AGENDA-AT-A-GLANCE
PRE-CONFERENCE SHORT COURSE*
Tuesday, February 24 - 2:00 - 5:00 pm
(SC6) Best Practices in Translational Medicine, Drug Discovery
and Informatics
This course provides you with an inside look at several of the outstanding
Best Practices presented as a part of the 2008 Bio-IT World Best Practices
competition. Speakers will present their best practices, give updates to the
program and discuss pushing innovation, increasing ROI, and implementing
strategies that are the best in the industry. The forum will be invaluable
for building the innovative partnerships and strategies that will keep
pushing the industry forward. * Separate registration is required.
MAIN CONFERENCE
February 25-27, 2009
INTEGRATED R&D - DRIVING PRODUCTIVITY, INNOVATION & MANAGING RESOURCES &
COSTS
PLENARY KEYNOTE:
Using Molecular Medicine to do Therapeutic Development in the Network Age
Jay M. Tenenbaum, Ph.D., Chairman and Chief Scientist, CollabRx, Inc.
Scientific Workflows as Productivity Tools for Drug Discovery
Juergen Hammer, Ph.D., M.Sc., M.B.A., Global Research Informatics Director,
Group Research Information- Global Head in silico Sciences - Center Head -
Liaison to Pharma Research, Hoffmann-La Roche Inc.
The Role of Informatics and Genomics to Drive Innovation in Pharma
Jakob DeVlieg, Ph.D., Global Head Molecular Design & Informatics, Molecular
Design & Informatics, Schering-Plough
Evolution of an Innovation Model to Support Pharma R&D
Martin D. Leach, Ph.D., Executive Director, MRL IT Basic Research &
Biomarkers, Merck & Co. Inc.
RISé - Research Informatics System at RISé
Ajay Shah, Ph.D., M.B.A., P.M.P., Director, Research Informatics, Elan
Pharmaceuticals Inc. Sponsored by: Symyx
Resource Management Strategies Impacting Systems Integration in R&D
David M. Sedlock, Ph.D.. Senior Director, R&D Systems, Millennium
Pharmaceuticals The TAKEDA Oncology Company
Democratized Serendipity: Leveraging Consumer-Oriented Technologies into
Better R&D and Better Health Care Decisions
Joseph A. Cerro, President, The Schooner Group, LLC
Executive Panel:
Integrated R&D, How Far Have We Come?
Moderator: Susan Ward, Ph.D.,Executive Advisor, Biotechnology & Pharma
Panelists: All of the above speakers
TRANSLATIONAL RESEARCH INFORMATICS
Enterprise Information Integration to Inform Biomarker Discovery and
Development: Clinical Patient, Biosample and Omics Data
Gary Mallow, Ph.D., Director, Biomarker Programs, Information Services for
Basic Research, Merck & Co., Inc.
A Nationwide Network to Enable Translational Research
Ken Buetow, Ph.D., NCI Associate Director, Bioinformatics and Information
Technology and Director, Center for Biomedical Informatics and Information
Technology, National Cancer Institute
Translating Between Pre-clinical Data and Clinical Outcomes: Successes and
Challenges
Anastasia M. Khoury Christianson, Ph.D., Senior Director and Global
Discipline Leader, Biomedical Informatics, AstraZeneca R&D Wilmington
How to get the Most Out of Published Findings: Improving Information Flow
and Knowledge Enrichment Throughout Discovery
Nikolai Daraselia, Ph.D., Senior Director of Research, Ariadne
Sponsored by Ariadne
Scientific Informatics: The Integration of Information and Process to
Achieve Knowledge Re-Use
Frank K. Brown, Ph.D., Vice President & Chief Science Officer, Accelrys
Sponsored by Accelrys
Integrated Informatics - Are We There Yet?
Sandor Szalma, Ph.D., Director, R&D Informatics, Centocor R&D Inc.
Panel: Bridging the Divide
Moderator: John Russell, Executive Editor, Bio-IT World
Panelists: All of the above speakers
Analysis of Genome-wide Genotyping Data for Copy Number Variation in Breast
Cancer
Aubree Hoover, Senior Product Manager, Rosetta Biosoftware
Sponsored by Rosetta Biosoftware
PLENARY KEYNOTE
Engineering Cells to Death
James A. Wells, Ph.D., Professor and Chair of Pharmaceutical Chemistry, and
Professor of Cellular & Molecular Pharmacology, University of California,
San Francisco
PLENARY KEYNOTE
Brave New Age of Personalized Medicine
David Ewing Duncan, Chief Correspondent, NPR Talk's "Biotech Nation" and
Best Selling Author "Masterminds"
DATA, INFORMATION AND KNOWLEDGE MANAGEMENT
Tales from the Edge: Advanced Approaches to Knowledge Integration & Search
David M. Hodgson, Site Head, Global Research Informatics & Global Head,
Group Knowledge Exchange, Roche
A Strategy for Internal-External Data and Information Integration
Jason M. Johnson, Ph.D., Senior Director, Molecular Informatics, Merck &
Co., Inc.
Accelerating Research Through Information Exploitation
Chris Waller, Ph.D., Senior Director, Chemistry Informations, Research and
Development Informatics, Worldwide Technology, Pfizer, Inc.
Integrating Public and Private Data
Reece Hart, Ph.D., Scientific Manager, Research Computing & Informatics,
Genentech Inc.
INTEGRATING GENOMIC DATA
The Genomic Data Pipeline: Collecting, Cleaning, Analyzing, Integrating,
Sharing
Jeanette Papp, Ph.D., Associate Professor, Human Genetics, University of
California, Los Angeles
Surviving the Data Deluge: Informatics for Next Generation Sequencing
Toby Bloom, Ph.D, Director of Informatics, Genome Sequencing Platform, The
Broad Institute
Integrating Public Genomics Data into Pharmaceutical R&D
Hans-Martin Will, Ph.D., Senior Director, Genomics R&D, Rosetta Biosoftware
Search Strategies for Correlating Combined Public and Internal Large-Scale
Studies
Ilya Kupershmidt, Cofounder and Vice President Products, NextBio
Sponsored by NextBio
Panel: Meeting of the Minds
Those who Generate the Data with Those who Store, Analyze and Integrate Data
DATA INTEGRATION AND MANAGEMENT FOR EARLY AND LATE CHEMISTRY
Lilly's Transition from Paper to Electronic Lab Notebooks
Keith DeVries, Ph.D., Director, Chemical Product, R&D, Eli Lilly and
Company, Lilly Research Labs
Integration of Chemical Genomics and Structural Biology Informatics: Novel
Insights into the Kinase Gene Family?
Stephan Schürer, Ph.D., Department of Pharmacology, Miller School of
Medicine & Center for Computational Science, University of Miami
Techniques for Effective Integrated Access to Large Compound-oriented Drug
Discovery Databases
Michael, Lajiness, Ph.D., Research Scientist, Structural and Computational
Sciences, Eli Lilly & Company
*separate registration is required to attend pre-conference short course.
http://www.tri-conference.com/09_ird.asp
For more information, contact:
Cambridge Healthtech Institute
Tel: 781-972-5400
E-mail: jprudhomme at healthtech.com
More information about the BBB
mailing list